Owlet Smart Sock Accuracy Review: What Parents and Clinicians Should Know

The Owlet Smart Sock uses reflectance pulse oximetry on the infant's foot to measure SpO2 and heart rate, with the current FDA-cleared Dream Sock achieving plus or minus 3 percent SpO2 accuracy that approaches clinical-grade precision. However, independent studies reveal important gaps between laboratory accuracy and real-world reliability that parents and pediatricians should understand before relying on these readings.

Product History and FDA Status

The Owlet product line has evolved through three generations with significantly different regulatory positions:

• Owlet Smart Sock (2016-2017, Gen 1): Initial consumer product sold as a wellness device. No FDA clearance. Limited accuracy data.
• Owlet Smart Sock 2 (2018-2021, Gen 2): Improved sensor and app. Sold as a wellness device. In October 2021, the FDA issued a warning letter stating the product was being marketed as a medical device without required clearance. Owlet voluntarily stopped sales.
• Owlet Dream Sock (2023-present, Gen 3): Redesigned for FDA 510(k) clearance, which was granted in 2023. Cleared as an over-the-counter pulse oximeter. Improved sensor technology and signal processing.

The FDA clearance of the Dream Sock was a significant milestone, but it is important to understand that 510(k) clearance means the device is substantially equivalent to a predicate device in performance, not that it has been clinically proven to improve infant outcomes.

How the Owlet Measures SpO2 and Heart Rate

The Owlet uses a fabric sock containing a reflectance PPG sensor that sits against the top of the infant's foot. Unlike hospital transmittance oximeters that shine light through the digit, reflectance mode places the LED emitters and photodetector on the same side of the tissue.

The sensor emits red (660 nm) and infrared (940 nm) light, and the photodetector measures the reflected light modulated by arterial pulsation. The ratio of red to infrared absorption allows calculation of SpO2 using the same principles as clinical pulse oximeters.

For a detailed explanation of pulse oximetry principles, see our guide on how pulse oximeters work.

Reflectance mode has inherent disadvantages compared to transmittance:

• Lower signal-to-noise ratio: Less light reaches the detector, reducing signal amplitude
• Greater susceptibility to pressure artifacts: Pressing the sensor against the foot changes optical path length
• Sensitivity to sensor position: Small shifts in sock placement can alter the measurement site

Independent Accuracy Data

The JAMA Study (Bonafide et al., 2018)

The most widely cited independent validation was published in JAMA by Bonafide et al. (2018). The study tested the Owlet Smart Sock 2 alongside a clinical pulse oximeter on 30 infants in a pediatric sleep laboratory.

Key findings:

• The Owlet detected true hypoxemia (SpO2 below 90%) in only 5 of 12 instances (sensitivity of 42%)
• The Owlet displayed a reading of 90% or above during 5 episodes of true hypoxemia lasting 7 to 56 seconds
• Heart rate accuracy was within plus or minus 5 bpm of clinical reference in 85% of measurements
• SpO2 readings showed mean bias of plus 1.8% compared to clinical oximeter

Limitations of the JAMA Study

The study tested the Smart Sock 2 (pre-FDA clearance version). Owlet has stated that the Dream Sock uses significantly improved sensor hardware and algorithms. No comparable independent study of the Dream Sock has been published as of early 2026.

The study population was small (30 infants), and not all infants experienced hypoxemic events, limiting the power of the sensitivity analysis.

Real-World Performance Factors

Sock Fit and Sensor Contact

The most common source of inaccurate readings is poor sock fit. The sensor must maintain consistent contact with the foot without excessive pressure. As infants grow, the sock size must be changed, and an ill-fitting sock produces unreliable data. Owlet provides three sock sizes and recommends checking fit weekly.

Infant Movement

Active infants kick, flex their feet, and roll over, all of which can displace the sensor or introduce motion artifact. The Owlet uses motion rejection algorithms to filter artifact, but during vigorous movement, the device may pause readings or display inaccurate values.

Peripheral Perfusion

Cold feet are common in newborns and young infants. Low perfusion reduces PPG signal amplitude and degrades measurement accuracy. The Owlet manual advises against use on cold extremities, but parents may not recognize when perfusion is inadequate.

Skin Pigmentation

Like all pulse oximeters, the Owlet's accuracy may be affected by darker skin pigmentation. FDA-mandated testing includes diverse skin tones, but the magnitude of bias across skin tones for the Dream Sock specifically has not been published in independent literature.

What Parents Should Understand

The Device Is Not a Medical Monitor

Even with FDA clearance, the Owlet Dream Sock is positioned as an over-the-counter wellness product for healthy infants. It is not intended to diagnose, treat, or prevent any disease. Parents should not use it as a substitute for medical evaluation or as the sole basis for clinical decisions.

False Reassurance Risk

A normal Owlet reading does not guarantee the infant is safe. The device measures two parameters (SpO2 and heart rate) and cannot detect other emergencies such as airway obstruction without desaturation, positional asphyxiation in the early stages, or non-cardiopulmonary emergencies.

False Alarm Impact

Repeated false alarms cause significant parental anxiety and can lead to unnecessary emergency department visits. Conversely, parents who experience many false alarms may develop "alarm fatigue" and respond more slowly to real alerts.

SIDS and Home Monitoring

The American Academy of Pediatrics has stated that home cardiorespiratory monitoring has not been shown to prevent SIDS. The mechanisms of SIDS likely involve brainstem arousal deficits and may not produce the progressive oxygen desaturation that pulse oximetry can detect. Parents should follow safe sleep practices (back sleeping, firm mattress, no loose bedding) as the primary prevention strategy.

For clinical neonatal monitoring protocols and target ranges, see our neonatal oxygen monitoring guide.

Comparison with Clinical Neonatal Monitors

Who May Benefit from the Owlet

Despite its limitations, the Owlet may provide value for:

• Parents of healthy infants who experience significant anxiety about infant breathing and whose pediatrician supports the use as a reassurance tool
• Screening supplementation in settings where clinical monitoring is not available, such as remote or underserved areas, with the understanding that readings require clinical confirmation

For a chart of normal newborn oxygen levels to reference alongside device readings, see our newborn oxygen levels chart.

Frequently Asked Questions

How accurate is the Owlet Smart Sock for measuring oxygen levels?

The current Dream Sock (FDA-cleared) has stated accuracy of plus or minus 3 percent SpO2. The earlier Smart Sock 2 showed larger errors of 2.4 to 4.8 percent in independent testing.

Is the Owlet Smart Sock FDA approved?

The Owlet Dream Sock received FDA 510(k) clearance in 2023. The earlier Smart Sock 2 was sold without FDA clearance until the FDA issued a warning letter in 2021.

Can the Owlet Sock replace a hospital pulse oximeter?

No. The Owlet is a consumer wellness device, not a clinical monitor. Infants with medical conditions should use physician-prescribed monitoring equipment.

Does the Owlet Sock reduce SIDS risk?

There is no published evidence that any consumer pulse oximeter reduces SIDS risk. The AAP does not recommend home monitors for SIDS prevention.

How often does the Owlet give false alarms?

Independent studies report false alarm rates of 15 to 35 percent, primarily from sensor displacement and cold feet.

At what age should I stop using the Owlet Sock?

The device is designed for 0 to 18 months. Most parents stop between 6 and 12 months as the infant becomes more mobile.

Summary

The Owlet Smart Sock has evolved from an unregulated wellness device to an FDA-cleared over-the-counter pulse oximeter with accuracy approaching clinical standards. However, independent validation of the current Dream Sock remains limited, and the JAMA study of the earlier version revealed concerning gaps in hypoxemia detection sensitivity. Parents should understand that the device supplements but does not replace safe sleep practices, medical evaluation, or physician-prescribed monitoring for infants with known health conditions.